Clinical & translational oncology

• 

  Año 2022, Vol. 24, Número 8

  • CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target

    Lan Li, Liping Zhong, Chao Tang, Lu Gan, Tong Mo, Jintong Na, Jian He, Yong Huang

    • Resumen

    págs. 1447-1458

    

  • Autophagy in acute myeloid leukemia: a paradoxical role in chemoresistance

    Aafreen Khan, Vivek Kumar Singh, Deepshi Thakral, Ritu Gupta

    • Resumen

    págs. 1459-1469

    

  • The role of the inflammasome and its related pathways in ovarian cancer

    Chenxi Liu, Xuemei Huang, Hongling Su

    • Resumen

    págs. 1470-1477

    

  • The clinical and prognostic significance of CMTM6/PD-L1 in oncology

    Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani

    • Resumen

    págs. 1478-1491

    

  • BAG family proteins contributes to autophagy-mediated multidrug resistance of tumor

    Jufang Guo, Xuelian Du, Chaolin Li

    • Resumen

    págs. 1492-1500

    

  • Research progress on epigenetics of small B-cell lymphoma

    Xueqin Ruan, Rong Zhang, Hongkai Zhu, Can Ye, Zhihua Wang, En Dong, Ruijuan Li, Zhao Cheng, Hongling Peng

    • Resumen

    págs. 1501-1514

    

  • Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus

    Begoña Campos Balea, Ovidio Fernández Calvo, Roberto García Figueiras, Carlos Neira de Paz, Carmen Peña Penabad, Carmela Rodríguez López, Rocío Vílchez Simo, María Quindós Varela

    • Resumen

    págs. 1515-1523

    

  • P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer

    Junjie Zhang, Yang Dong, Zhenduo Shi, Houguang He, Jiangang Chen, Shaoqi Zhang, Wei Wu, Qianjin Zhang, C. H. Han, Lin Hao

    • Resumen

    págs. 1524-1532

    

  • The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma

    Cem Onal, Pervin Hurmuz, Ozan Cem Guler, Guler Yavas, Burak Tilki, Ezgi Oymak, Cagdas Yavas, Gokhan Ozyigit

    • Resumen

    págs. 1533-1541

    

  • Interval cytoredutive surgery and HIPEC in advanced ovarian cancer with small-bowel disease: results and reflections

    Pedro Antonio Cascales Campos, Alida Gonzalez Gil, A. J. Gómez Ruiz, Andrés Balaguer Román, Elena Gil, Felipe Alconchel Gago, Jerónimo Martinez Garcia, Anibal Nieto Díaz, Francisco Barceló Valcárcel, José Gil Martínez

    • Resumen

    págs. 1542-1548

    

  • Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review

    María Guirado, Elena Fernández Martín, Alberto Fernández Villar, Arturo Navarro Martín, A. Sánchez

    • Resumen

    págs. 1549-1568

    

  • The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer

    Xiang Fang, Huiying Shi, Fang Sun

    • Resumen

    págs. 1569-1579

    

  • Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group

    María Aránzazu Eraso Urién, Javier Sanz Latiesas, Meritxell Mollà Armadà, Victoria Reyes López, Agustí Pedro, Meritxell Arenas Prat, Evelyn Martínez, Rosa Ballester Alabau, Maria Jose Cambra Seres, V. García Reglero, Joan Prades, Josep Maria Borràs Andrés, Manuel Ignacio Algara López

    • Resumen

    págs. 1580-1587

    

  • European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments

    Marilina Santero, Adriana Gabriela Meade, Roberto Acosta Dighero, Lucas González, Santiago Melendi, Ivan Solà Arnau, G. Urrutia Cuchi, Maria Jesus Quintana, X. Bonfill

    • Resumen

    págs. 1588-1604

    

  • Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis

    N.R. Gómez Hidalgo, Úrsula Acosta, Tomás Gómez Rodríguez, Soraya Mico, R. Vergés, Vicente Bebia Conesa, Melissa Bradbury Lobato, Santiago Pérez-Hoyos, María Asunción Pérez Benavente, Antonio Gil Moreno

    • Resumen

    págs. 1605-1614

    

  • Development of a prognostic metabolic signature in stomach adenocarcinoma

    Yu Gong, Siyuan Wu, Sen Dong, Shuai Chen, Gengdi Cai, Kun Bao, Haojun Yang, Yuwen Jiao

    • Resumen

    págs. 1615-1630

    

  • Study on the mechanism of let-7a-5p in regulating the proliferation in cervical cancer cells

    Zhiqin Chen, Jiahui Qiu, Yuling Gao, Qin Lu, Ying Lin, Hong Shi

    • Resumen

    págs. 1631-1642

    

  • Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study

    Yuzhong Cui, Wei Huang, Feng Du, Xiaoyang Yin, Lei Feng, Baosheng Li

    • Resumen

    págs. 1643-1656

    

  • Accelerated partial breast irradiation (APBI)

    Ana Manterola Burgaleta, Gemma Asín Felipe, Fernando Arias de la Vega

    págs. 1657-1658